Back to User profile » Dr Nanshan Zhong

Papers published by Dr Nanshan Zhong:


Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China

Hameed HMA, Fang C, Liu Z, Ju Y, Han X, Gao Y, Wang S, Chiwala G, Tan Y, Guan P, Hu J, Xiong X, Peng J, Lin Y, Hussain M, Zhong N, Maslov DA, Cook GM, Liu J, Zhang T

Infection and Drug Resistance 2022, 15:5655-5666

Published Date: 27 September 2022

Blood Eosinophils in Chinese COPD Participants and Response to Treatment with Combination Low-Dose Theophylline and Prednisone: A Post-Hoc Analysis of the TASCS Trial

Bradbury T, Di Tanna GL, Scaria A, Martin A, Wen FQ, Zhong NS, Zheng JP, Barnes PJ, Celli B, Berend N, Jenkins CR

International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:273-282

Published Date: 5 February 2022

Detection of Novel Gene Mutations Associated with Pyrazinamide Resistance in Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Southern China

Hameed HMA, Tan Y, Islam MM, Lu Z, Chhotaray C, Wang S, Liu Z, Fang C, Tan S, Yew WW, Zhong N, Liu J, Zhang T

Infection and Drug Resistance 2020, 13:217-227

Published Date: 22 January 2020

Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD

Chen R, Zhong N, Wang HY, Zhao L, Mei X, Qin Z, Huang J, Assam PN, Maes A, Siddiqui S, Martin UJ, Reisner C

International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:43-56

Published Date: 8 January 2020

Sputum Exosomal microRNAs Profiling Reveals Critical Pathways Modulated By Pseudomonas aeruginosa Colonization In Bronchiectasis

Huang Y, Chen C, Yuan J, Li H, Han X, Chen R, Guan W, Zhong N

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2563-2573

Published Date: 22 November 2019

Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled study

Ma JF, Zheng JP, Zhong NS, Bai CX, Wang HY, Du J, Li FL, Chen YW, Shi Z, Li X, Chen PY

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3107-3114

Published Date: 4 October 2018

Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD

Su ZQ, Guan WJ, Li SY, Ding M, Chen Y, Jiang M, Chen XB, Zhong CH, Tang CL, Zhong NS

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3031-3044

Published Date: 1 October 2018

Altered community compositions of Proteobacteria in adults with bronchiectasis

Guan WJ, Yuan JJ, Li HM, Gao YH, Chen CL, Huang Y, Chen RC, Zhong NS

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2173-2182

Published Date: 17 July 2018

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:339-349

Published Date: 19 January 2017

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

Vogelmeier C, Zhong NS, Humphries MJ, Mezzi K, Fogel R, Bader G, Patalano F, Banerji D

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:3189-3197

Published Date: 14 December 2016

LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD

Zhong N, Wang C, Zhou X, Zhang N, Humphries M, Wang L, Thach C, Patalano F, Banerji D

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1015-1026

Published Date: 5 June 2015